Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_assertion type Assertion NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_head.
- NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_assertion description "[In contrast, out of the 97 cases of invasive ductal carcinomas studied, 90 (93%) and 96 (99%) reacted positively with BC-I and FDC-6, respectively, the reaction being observed in the tumoral stroma connective tissue and in tumoral vessels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_provenance.
- NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_assertion evidence source_evidence_literature NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_provenance.
- NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_assertion SIO_000772 7927891 NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_provenance.
- NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_assertion wasDerivedFrom befree-2016 NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_provenance.
- NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_assertion wasGeneratedBy ECO_0000203 NP1327305.RALXeZMS1b3N07rdnmWYS765fRw0X6R4hIh_ql59x0Xf8130_provenance.